World's Best Scientists 2026 revealed!
Diethelm Wallwiener

Diethelm Wallwiener

D-Index & Metrics

Medicine

D-Index
77
Citations
22854
World Ranking
18391
National Ranking
968

Overview

Diethelm Wallwiener is affiliated with the University of Tübingen in Germany and has an extensive research portfolio primarily in the fields of medicine and biochemistry, genetics, and molecular biology. Their work encompasses a significant focus on oncology, with contributions covering various aspects of cancer research including pulmonary and respiratory medicine, genetics, and surgery.

The scientist's publication record includes numerous articles in peer-reviewed journals, with frequent contributions to leading venues such as Geburtshilfe und Frauenheilkunde, Senologie - Zeitschrift für Mammadiagnostik und -therapie, Archives of Gynecology and Obstetrics, European Journal of Cancer, and Cancers.

Key research topics covered by Diethelm Wallwiener include:

  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Cells and Metastasis

Notable recent papers authored or co-authored by Diethelm Wallwiener are:

  • Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status, 2021, European Journal of Cancer
  • Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis, 2021, Journal of Clinical Oncology
  • Living-Donor Uterus Transplantation: Pre-, Intra-, and Postoperative Parameters Relevant to Surgical Success, Pregnancy, and Obstetrics with Live Births, 2020, Journal of Clinical Medicine
  • Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial, 2024, Clinical Chemistry
  • Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany, 2020, The Breast

Throughout their career, Diethelm Wallwiener has collaborated extensively with a group of frequent co-authors, including Sara Y. Brucker, Tanja Fehm, Andreas Schneeweiß, Peter A. Fasching, and Andreas D. Hartkopf. These collaborations have contributed to a substantial body of work primarily centered on breast cancer treatment and diagnostics.

Wallwiener's research spans both clinical studies and molecular investigations, with a particular emphasis on therapeutic approaches and diagnostic advancements in oncology. Their contributions cover the clinical outcomes of breast cancer therapies, mutations affecting prognosis, and surgical parameters relevant to transplantation and birth outcomes.

Best Publications

  • Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

    Ingo J. Diel;Erich-Franz Solomayer;Serban D. Costa;Christina Gollan

  • Clinical aspects of Mayer–Rokitansky–Kuester–Hauser syndrome: recommendations for clinical diagnosis and staging

    Peter Oppelt;Stefan P. Renner;Anja Kellermann;Sara Brucker

  • Detection and Typing of Human Papillomavirus by E6 Nested Multiplex PCR

    K. Sotlar;D. Diemer;A. Dethleffs;Y. Hack

  • HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

    Tanja Fehm;Volkmar Müller;Bahriye Aktas;Wolfgang Janni

  • Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

    Sabine Kasimir-Bauer;Oliver Hoffmann;Diethelm Wallwiener;Rainer Kimmig

  • Proteomics of Human Breast Ductal Carcinoma in Situ

    Julia D. Wulfkuhle;Dennis C. Sgroi;Henry Krutzsch;Kelley McLean;Kelley McLean

  • Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.

    Christina S. Schuetz;Michael Bonin;Susan E. Clare;Kay Nieselt

  • Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

    Tanja Fehm;Oliver Hoffmann;Bahriye Aktas;Sven Becker

  • The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations.

    Peter Oppelt;Stefan P. Renner;Sara Brucker;Pamela L. Strissel

  • A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

    Tanja Fehm;Stephan Braun;Volkmar Muller;Wolfgang Janni

  • Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.

    J. Huober;J. Huober;P.A. Fasching;P.A. Fasching;M. Barsoum;L. Petruzelka

  • Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

    Claudia Lengerke;Tanja Fehm;Ralf Kurth;Hans Neubauer

  • Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

    Tanja Fehm;Sven Becker;Silke Duerr-Stoerzer;Karl Sotlar

  • High prevalence of viral genomes and inflammation in peripartum cardiomyopathy.

    Burkhard D. Bültmann;Karin Klingel;Michael Näbauer;Diethelm Wallwiener

  • Is human chorionic gonadotropin directly involved in the regulation of human implantation

    P. Licht;H. Fluhr;J. Neuwinger;D. Wallwiener

  • Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer

    Ines Gruber;Miriam Rueckert;Karl Oliver Kagan;Annette Staebler

  • Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.

    Axel Hoos;Axel Hoos;Hedwig H. Hepp;Sepp Kaul;Thorsten Ahlert

  • PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study

    Brigitte Smyczek-Gargya;Nikos Fersis;Helmut Dittmann;Ulrich Vogel

  • A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance.

    Thorsten Kuehn;Andreas Bembenek;Thomas Decker;Dieter Ludwig Munz

  • Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid.

    D. Hornung;F. Bentzien;D. Wallwiener;L. Kiesel

Frequent Co-Authors

Tanja Fehm
Tanja Fehm Heinrich Heine University Düsseldorf
Andreas Schneeweiss
Andreas Schneeweiss German Cancer Research Center
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Matthias W. Beckmann
Matthias W. Beckmann University of Erlangen-Nuremberg
Volkmar Müller
Volkmar Müller Universität Hamburg
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Michael Untch
Michael Untch Helios Klinikum Berlin-Buch
Christoph Thomssen
Christoph Thomssen University of Göttingen
Jens Huober
Jens Huober Kantonsspital St. Gallen
Arnulf Stenzl
Arnulf Stenzl University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medical careers beyond traditional doctor routes? Many students considering studying Medicine in the USA also explore other respected healthcare pathways—and online options make these fields more accessible than ever.

For those drawn to pharmaceuticals, consider pursuing pharmacy school online, which allows you to continue working or meeting other obligations while earning a degree. Similarly, if managing health data interests you, accredited him programs offer a flexible route to careers in data management, compliance, and informatics.

Medical billing and coding is another respected field, and understanding medical coding certification cost can help you budget for one of the fastest-growing allied health careers. Nursing remains an ever-popular healthcare path, with numerous cheapest fnp programs online letting you prepare for advanced practice roles affordably.

Exploring these alternative degrees can expand your career options, allow greater work-life balance, and help you find a healthcare role that best matches your strengths and interests.

Best Scientists Citing Diethelm Wallwiener

Trending Scientists